The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.

Say goodbye to the classic ClinicalTrials.gov!

The classic ClinicalTrials.gov website will be retired on June 25, 2024. Please use the modernized ClinicalTrials.gov. For more information, see ClinicalTrials.gov Modernization.

Key Record Dates

ClinicalTrials.gov Identifier:	NCT05048797
Brief Title:	A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations

First Submitted :	September 9, 2021
First Submitted that Met QC Criteria :	September 9, 2021
First Posted :	September 17, 2021

Last Update Submitted that Met QC Criteria :	May 14, 2024
Last Update Posted :	May 16, 2024

To Top